News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Kohei Shitara։ DG04 Took 3.5+ Years for HER2 Confirmation
Kohei Shitara/X
Jul 26, 2025, 07:32

Kohei Shitara։ DG04 Took 3.5+ Years for HER2 Confirmation

Kohei Shitara, Director of National Cancer Center Hospital East, shared a post on X:

“DG04 officially published NEJM, ASCO.

This comes 10 years after my first phase 1 patient. DG04 took 3.5+ years due to <15% HER2+ and fresh biopsy to confirm HER2. Grateful for global effort—hoping this expands T-DXd access worldwide.”

Title: Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Authors: Kohei Shitara, Eric Van Cutsem, Mahmut Gümüş, Sara Lonardi, Christelle de la Fouchardière, Clélia Coutzac, Jeroen Dekervel, Daniel Hochhauser, Lin Shen, Wasat Mansoor, Bo Liu, Lorenzo Fornaro, Min-Hee Ryu, Jeeyun Lee, Cátia Faustino, Jean-Philippe Metges, Josep Tabernero, Fábio Franke, Yelena Y. Janjigian, Fabricio Souza, Lori Jukofsky, Yumin Zhao, Takahiro Kamio, Aziz Zaanan, Filippo Pietrantonio

Read full article on NEJM.

Kohei Shitara։ DG04 Took 3.5+ Years for HER2 Confirmation

More post featuring Kohei Shitara on OncoDaily.

ASCO Aziz Zaanan Bo Liu cancer Cátia Faustino CHRISTELLE DE LA FOUCHARDIERE Clelia Coutzac Daniel Hochhauser Eric van Cutsem Fabio Franke Fabricio Souza Filippo Pietrantonio Jean-Philippe Metges Jeeyun Lee Jeroen Dekervel Josep Tabernero Kohei shitara Lin Shen Lorenzo Fornaro Lori Jukofsky Mahmut Gümüş Min-Hee Ryu NEJM OncoDaily Oncology Sara Lonardi Takahiro Kamio Wasat Mansoor Yelena Y. Janjigian Yumin Zhao
Special Coverage
Blog
Jul 26, 2025, 20:13
Ready to Take Your Cancer Research Career to the Next Level? - EACR
Blog
Jul 26, 2025, 20:00
EU’s Medicine Strategy is Focused on Supply Chains, But Overlooks the Deeper Risk
Blog
Jul 26, 2025, 19:45
Siddharth Sreemahadevan: I was Honored to Be Declared Second Runner-Up in the 8th SPEAK Lymphoma Programme
Opinion
Jul 26, 2025, 19:31
The AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows
Blog
Jul 26, 2025, 19:14
Bishal Gyawali: Calling the Family of My Patients After They Have Passed Away - It’s the Least We Can Do
Science
Jul 26, 2025, 18:38
Incorporating Evidence-Based Approaches for Patients With GI Cancers - Society for Integrative Oncology
Blog
Jul 26, 2025, 17:31
Massimo Di Maio: A Great Opportunity Of Scientific And Cultural Exchange In Beijing
Blog
Jul 26, 2025, 16:51
The Role of Peer-to-Peer Fundraising - Conquer Cancer, The ASCO Foundation
Insight
Jul 26, 2025, 16:40
World Hepatitis Day - ELPA
Career
Jul 26, 2025, 15:51
Alisher Kahharov Has Started a New Role as Head of the Breast Cancer Surgery Department at the National Cancer Center
Science
Jul 26, 2025, 15:43
Myeloma Paper of the Day, July 26th, Suggested by Robert Orlowski
Blog
Jul 26, 2025, 15:15
Prashant Kumar: How to Detect, Monitor, and Treat Disease-Ushering in a Personalized Era of Care